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Ubiquitin-Mediated Proteasome Activity Is
Required for Agonist-Induced Endocytosis of GluRs
meaningful analysis of synaptic localization, but we did
determine the overlap between the proteasome and a
synaptic marker, synaptophysin (Figure 1C), by examin-
Gentry N. Patrick,1 Baris Bingol,1
Holli A. Weld, and Erin M. Schuman*
California Institute of Technology
Howard Hughes Medical Institute ing whether the regions of greatest intensity for protea-
some staining corresponded to synaptic sites. We ob-Division of Biology, 114-96
Pasadena, California 91125 served examples of colocalization of the two signals,
as well as examples where there was no overlap at all
between the two signals: 40.7%  2.3% of the pro-
teasome puncta overlapped with the synaptophysinSummary
puncta, whereas 57.8%  2.5% of the synaptophysin
puncta overlapped with the proteasome.Recent studies documenting a role for local protein
synthesis in synaptic plasticity have lead to interest
in the opposing process, protein degradation, as a
Proteasome Inhibitors Prevent Agonist-potential regulator of synaptic function [1–7]. The ubi-
Stimulated Internalization of GluR1 and 2quitin-conjugation system identifies, modifies, and de-
To address initially the role of protein degradation inlivers proteins to the proteasome for degradation
the regulation of synaptic function, we asked whether[8, 9]. We found that both the proteasome and ubiquitin
proteasome activity is required for the glutamate-are present in the soma and dendrites of hippocampal
induced internalization of AMPA-type (-amino-3-hydroxy-neurons. As the trafficking of glutamate receptors
5-methyl-4-isoxazole propionic acid) GluRs that have(GluRs) is thought to underlie some forms of synaptic
been proposed to underlie some forms of synaptic plas-plasticity [10, 11], we examined whether blocking pro-
ticity [10, 12–14]. Dissociated hippocampal neuronsteasome activity affects the agonist-induced internal-
were live labeled with a primary antibody recognizingization of GluRs in cultured hippocampal neurons.
an extracellular epitope of either GluR1 or 2 and thenTreatment with the glutamate agonist AMPA induced
treated with the glutamate agonist AMPA to induce en-a robust internalization of GluRs. In contrast, brief pre-
docytosis of labeled receptors. The residual surface an-treatment with proteasome inhibitors completely pre-
tibody was removed (see Supplemental Experimentalvented the internalization of GluRs. To distinguish
Procedures); neurons were fixed, then permeabilizedbetween a role for the proteasome and a possible
and treated with a fluorescent secondary antibody todiminution of the free ubiquitin pool, we expressed a
label the internalized glutamate receptors. As reportedchain elongation defective ubiquitin mutant (UbK48R),
by others [14–16], brief treatment with AMPA resultedwhich causes premature termination of polyubiquitin
in a robust (6- to 8-fold) internalization of either GluR1chains but, importantly, can serve as a substrate for
or GluR2 (Figures 2A–2D). In contrast, AMPA-stimulatedmono-ubiquitin-dependent processes. Expression of
endocytosis of GluR1 and 2 was completely preventedK48R in neurons severely diminished AMPA-induced
by a brief (20 min) pretreatment with the proteasomeinternalization establishing a role for the proteasome.
inhibitor MG132 [17] or ZL3VS [17] (Figures 2A–2D). Simi-These data demonstrate the acute (e.g., minutes) regu-
lar inhibition was also observed with a third specificlation of synaptic function by the ubiquitin-protea-
proteasome inhibitor, lactacystin (mean fold internaliza-some pathway in mammalian neurons.
tion of GluR2: control, 1.0 0.38, n 14; AMPA, 5.88
1.39, n  28; lactacystin, 0.42  0.24, n  48). FiguresResults and Discussion
2C and 2D show the analysis of somatic immunofluores-
cence; proteasome inhibition also prevented the AMPA-Ubiquitin and Subunits of the Proteasome Are
induced internalization of dendritic GluRs (mean foldHeterogeneously Distributed in Dendrites
internalization of dendritic GluR1: control, 1.00  0.13,If ubiquitin-regulated protein degradation is used during
n [dendrites] 42; AMPA, 6.47 1.86, n 38; AMPAsynaptic plasticity then the molecular components re-
MG132, 1.38  0.40, n  45; mean fold internalizationquired, including ubiquitin and the proteasome, should
of dendritic GluR2: control, 1.00  0.20, n  38; AMPA,be present in neuronal dendrites near synapses. Immu-
7.39  2.87, n  40; AMPA  MG132, 1.12  0.20, n nofluorescent labeling in cultured hippocampal neurons
39). The complete inhibition of AMPA-induced internal-indicated that dendrites indeed contain both the protea-
ization of GluR1 and GluR2 observed in the presencesome and ubiquitin (Figure 1A and Supplemental Figure
of proteasome inhibitors indicates a requirement for pro-S1). Strong signal for ubiquitin was present in both the
tein degradation in AMPA receptor trafficking.cell body and throughout the dendrites. A similar distri-
Activation of NMDA (n-methyl-D-aspartate) receptorsbution pattern was observed for the proteasome: strong
can also induce internalization of GluRs [14]. We foundstaining was evident in the cell bodies, and punctate
that proteasome inhibitors also prevent the NMDA-high-intensity clusters were observed in the dendrites
induced internalization of GluR1 (Figure 2E). Previous(Figure 1B). The abundance of ubiquitin precludes a
studies have suggested different intracellular signals for
AMPA versus NMDA-induced internalization of the re-*Correspondence: schumane@its.caltech.edu
1These authors contributed equally to this work. ceptors (e.g., [16]); the blockade of both AMPA- and
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Figure 1. Presence of Ubiquitin and the Proteasome in the Soma and Dendrites of Hippocampal Neurons
Shown are dissociated hippocampal neurons immunostained with an antibody directed against ubiquitin (A) or the proteasome (B). The color
intensity profile shows the intensity of fluorescence from low (blue-black) to high (white; see color lookup bar in top left image). Images show
that both ubiquitin and the proteasome are abundant in both the soma and dendrites of hippocampal neurons. Positive staining is abundant
in the dendritic arbor. High-magnification images (below) show intense immunoreactivity in the dendrites and putative spines. Scale bar, 15
m. (C) Some of the proteasome staining (green) overlaps with that of a synaptic marker, synaptophysin (red). In the image shown, 42.7% of
the proteasome puncta overlaps with the synaptophysin puncta, and 56.6% of the synaptophysin puncta overlaps with the proteasome.
NMDA-induced internalization observed with protea- is required for the internalization of GluRs elicited by
either synaptically released or bath-applied agonists.some inhibitors indicates that at least part of the internal-
ization mechanism is shared.
The bath application of neurotransmitters to cultured Brief Inhibition of Proteasome Activity Does Not
Alter the Pool of Surface GluR1 or 2hippocampal neurons likely does not faithfully represent
the synaptic release of glutamate, since bath-applied As agonist-stimulated targets of the proteasome could
participate in the endocytosis, exocytosis, and/or inser-agonists can stimulate both synaptic and extrasynaptic
receptors (e.g., [18]). As such, we addressed whether tion of the glutamate receptors, we next examined whether
proteasome inhibition alters the pool of surface-expressedthe synaptic release of glutamate, elicited by bicuculline
treatment, can also stimulate the internalization of AMPA receptors available for endocytosis. Using antibody
labeling of live neurons, we compared the amount ofGluR1. We found that a 40 min treatment with bicuculline
(50 M) caused a 3.5-fold increase in internalized surface GluR1 or GluR2 immunoreactivity following 10
min, 40 min, or 2 hr treatments with MG132. Using theGluR1 relative to unstimulated controls (Figures 2F and
2G). These data indicate that the synaptic release of same data acquisition parameters that we used for our
internalization experiments, we found that none of thetransmitter can also induce the internalization of the
receptors. Moreover, we found that the bicuculline- MG132 treatments had a significant effect on the num-
ber of either GluR1 or GluR2 receptors detected on theinduced internalization was also blocked by a 20 min
pretreatment with MG132 (Figures 2F and 2G). Taken cell surface (Figures 3A and 3B). We do observe a sub-
stantial loss of surface receptors following AMPA treat-together, these data suggest that proteasome activity
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ment (data not shown). These results suggest that the ment) is sufficient to inhibit GluR endocytosis, sug-
gesting that free ubiquitin depletion cannot explain theinternalization of receptors stimulated by endogenous
glutamate release in our culture system is below the effects of proteasome inhibitors. To be sure that the
effects of MG132 cannot be attributed to free ubiquitindetection threshold of our experiments (e.g., [14]).
depletion, we conducted an additional experiment in
which the total duration of exposure to MG132 wasSpecificity: Internalization of the Transferrin
limited to 5 min (2.5 min pretreatment followed by 2.5Receptor Does Not Depend
min with AMPA). In this experiment, MG132 still inhibitedon Proteasome Activity
AMPA-stimulated GluR1 endocytosis, indicating a re-We addressed the specificity of proteasome action by
quirement for protein degradation (Figure 3G).determining whether ligand-stimulated endocytosis of
In order to examine further the role of polyubiquitina-the transferrin receptor exhibits a similar sensitivity to
tion, and hence proteasome activity, in AMPA-inducedproteasome inhibition. Application of transferrin to cells
GluR internalization, we used Sindbis virus to expressis known to induce a receptor-mediated internalization
a ubiquitin chain-elongation mutant (UbK48R) in whichof both transferrin and its receptor [19]––this can be
lysine at position 48, a site of ubiquitin attachment, isquantified by measuring the cytoplasmic accumulation
mutated to an arginine [26]. Expression of this constructof fluorescently labeled transferrin [20]. Using this tech-
thus allows monoubiquitination of proteins [25] but re-nique [21], we measured the receptor-mediated internal-
sults in abbreviated ubiquitin chain lengths for polyubi-ization of transferrin in cultured hippocampal neurons
quitinated proteins. We estimated that K48R was ex-(Figures 3C and 3D). Pretreatment of neurons with the
pressed at levels 10- to 12-fold higher than endogenousproteasome inhibitor MG132 did not affect the internal-
ubiquitin (Supplemental Figure S3). In control neuronsized pool of transferrin (Figures 3C and 3D). This result
expressing EGFP alone, we observed robust (7- to 12-indicates that proteasome activity is not required for the
fold) AMPA-induced internalization of both GluR1 andligand-induced internalization of all receptors in neurons.
2 (Figures 4C–4E). In contrast, in neurons expressingTo address whether proteasome activity is instructive
K48R (SinK48R-IRES-EGFP) the AMPA-induced GluRor permissive for GluR internalization, we manipulated
internalization was significantly inhibited (Figures 4C–the duration of proteasome inhibitor pretreatment prior
4E). Because monoubiquitination is allowed in neuronsto AMPA stimulation. We found that a mere 5 min pre-
expressing K48R, these results indicate a requirementtreatment with a proteasome inhibitor was sufficient to
for polyubiquitination in the internalization of the gluta-significantly inhibit AMPA-induced GluR1 internalization
mate receptors. Taken together with the proteasome(Figures 3E and 3F). Increasing the duration of protea-
inhibition data, these results show that ubiquitin-depen-some inhibitor pretreatment to 10 or 20 min yielded
dent degradation is essential for the AMPA-induced in-modest but not significant increases in the inhibition of
ternalization of GluRs.internalization (Figures 3E and 3F). That a very brief
proteasome pretreatment still inhibits receptor internal-
Localization of the Proteasome Complexization strongly supports the view that AMPA treatment
at or near Synapsesactively stimulates protein degradation, rather than the
Using immunofluorescent confocal microscopy, we ob-alternative view that there is constitutive degradation of
served that ubiquitin and the proteasome are abundanta protein(s) that is required for GluR internalization.
in dendrites, often present in or near putative spines.
These data suggest that the ubiquitination of proteins
Polyubiquitination Is Required for Agonist- at synapses could be followed by their degradation via a
Stimulated Internalization of GluR1 and 2 local proteasome. Recently, Ehlers demonstrated ATP-
In addition to blocking proteasome activity, proteasome dependent ubiquitin conjugation in both synaptosomal
inhibitors can also cause a diminution of the free ubiqui- and postsynaptic density preparations [5], indicating
tin pool: the inhibition of the proteasome leads to a build that ubiquitination can occur in or near synapses. In
up of polyubiquitinated proteins resulting in decreased addition, the components of the proteasome pathway
availability of free ubiquitin [22]. Because single ubiqui- have also been localized to retinal growth cones [3] and
tin molecules can be used as signals for endocytosis, Drosophila presynaptic terminals where local degrada-
independent of proteasome activity [23–25], it is impor- tion of a presynaptic protein has recently been observed
tant to assess the possible depletion of the ubiquitin in Drosophila nerve terminals [6]. Indeed, our data sug-
pool by proteasome inhibitors. We conducted a bio- gest that the proteasomal target protein(s) that regulates
chemical analysis of the free ubiquitin pool in lysates GluR internalization is degraded in the synaptic com-
prepared from hippocampal neurons treated with pro- partment, since degradation must precede the internal-
teasome inhibitors for 5, 20, or 40 min or 24 hr (e.g., [5]). ization of the receptor. These data raise the possibility
We found that treatment with MG132 (50 M) for 20 min, that the dynamic recruitment of the ubiquitin-protea-
40 min, or 24 hr resulted in significant reductions of free some complex to synaptic sites could be an important
ubiquitin (Figures 4A and 4B), whereas a 5 min treatment regulator of synaptic function.
had no significant effect. In contrast, treatment with
MG132 causes an increase in the levels of ubiquitinated Acute versus Long-Term Regulation
hippocampal proteins (Supplemental Figure S2). In Fig- of the Proteasome
ure 3, we demonstrated that a 5 min pretreatment with An important issue to consider is the timescale over
which the ubiquitin-proteasome pathway may regulateMG132 (followed by 20 min of AMPA  MG132 treat-
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Figure 2. Blockade of AMPA- or Bicuculline-Induced Internalization of GluR1 or GluR2 by Inhibitors of the Proteasome
(A) Shown are representative images of control, AMPA-, AMPA MG132-, or AMPA  ZL3VS-treated neurons in which internalization of GluR1
was monitored in dissociated hippocampal neurons. AMPA stimulation increased the pool of internalized GluR1 as measured with fluorescence
immunohistochemistry (see Supplemental Experimental Procedures). This agonist-induced internalization was blocked by brief (15–20 min)
pretreatment with either of two proteasome inhibitors MG132 or ZL3VS.
(B) Shown are representative images of control, AMPA-, AMPA  MG132-, or AMPA  ZL3VS-treated neurons in which internalization of
GluR2 was monitored in dissociated hippocampal neurons. AMPA stimulation increased the pool of internalized GluR2. This agonist-induced
internalization was blocked by brief (15–20 min) pretreatment with either of two proteasome inhibitors MG132 or ZL3VS.
(C) Summary data for GluR1 internalization experiments. AMPA treatment resulted in an average6-fold increase in fluorescence; this increase
was significantly inhibited (p  0.01) by either of two proteasome inhibitors. n (neurons) for each group: control, AMPA, AMPA  MG132,
AMPA  ZL3VS, n  33, 43, 21, and 25, respectively.
(D) Summary data for GluR2 internalization experiments. AMPA treatment resulted in an average 7.5-fold increase in fluorescence; this
increase was significantly inhibited (p  0.01) by either of two proteasome inhibitors. n for each group: control, AMPA, AMPA  MG132,
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synaptic function and plasticity. The work presented Different Roles for Ubiquitin in Modulating GluRs:
Mono versus Polyubiquitinationhere demonstrates an acute activation of the ubiquitin-
The attachment of a ubiquitin molecule to a protein canproteasome system; pretreatment with proteasome in-
serve as a signal for endocytosis, whereas the formationhibitors for 2.5 min was sufficient to block AMPA-
of polyubiquitin chains can serve as a recognition signalinduced endocytosis of GluRs. In addition, others have
for proteasomal degradation. Proteasome inhibitors canshown that proteasome inhibitors can abolish the netrin-
not unequivocally establish a role for degradation be-induced turning of growth cones in the time frame of
cause prolonged proteasome inhibition can lead to aone hour [3]. A similar rapid action of the proteasome
depletion of the free ubiquitin pool. Indeed, we observedwas recently reported at the Drosophila neuromuscular
inhibitor treatments as short as 20 or 40 min significantlysynapse [6] or Aplysia sensory-motor synapses [7]
reduced the free ubiquitin pool in hippocampal neurons.where proteasome inhibitors enhanced basal synaptic
These data indicate that effects observed following pro-transmission within an hour of their application. Taken
longed treatments with proteasome inhibitors are nottogether, our data and these other studies indicate that
sufficient to establish a requirement for proteasome ac-the ubiquitin-proteasome pathway can acutely regulate
tivity. In our experiments, however, we found that pre-synaptic function on a timescale of minutes. Alterna-
treatment with a proteasome inhibitor for as little as 5tively, Ehlers recently reported changes in synaptic pro-
min was sufficient to block AMPA-induced GluR endo-tein levels that result from global activity changes for
cytosis but had no effect on the free ubiquitin pool.24–48 hr; some of these changes were sensitive to pro-
Moreover, expression of a mutant ubiquitin molecule,teasome inhibitors [5]. It remains to be determined
K48R, which supports mono but not polyubiquitination,whether these observations represent a fundamentally
also prevented AMPA-induced GluR endocytosis. In thisdifferent type of regulation by the proteasome, which
respect, our data are similar to what has been describedoccurs on a longer timescale, or alternatively, represents
for several other ligand-receptor systems in which thethe cumulative effects of proteasomal regulation that
polyubiquitination and degradation of proteins are re-occurs on shorter timescales, e.g., minutes, as demon-
quired for the ligand-induced internalization of thestrated in this study.
receptor [21, 29, 30]. In addition, Zhao et al. recentlyWe provide evidence that activation of GluRs leads
reported an increase in the size of the glutamate-evokedto the regulation of ubiquitin proteasome system and
potential elicited in Aplysia motor neurons following athe degradation of a protein(s) required for the internal-
24 hr treatment with proteasome inhibitors, consistentization of the receptors. In principle, the target for prote-
with the idea that proteasome activity can regulate theolysis in this process could either be the glutamate re-
abundance of these glutamate receptors [7]. In contrast,ceptor itself or a protein(s) that normally prevents the
using genetic manipulations, Burbea et al. favor the idea
internalization of the receptor. The recognition of inter-
that ubiquitination of the C. elegans GLR-1 serves as
nalized GluRs by antibodies as well as the detection of
an endocytosis signal.
recycled receptors on the cell surface [16, 27, 28] are
not consistent with the idea that the receptor itself is
the target. It is more likely that a protein (or proteins) Conclusions
that interacts with the receptors, directly or indirectly, In summary, our data show that ubiquitin and the protea-
is the proteasomal target. Indeed, recent work has iden- some are present in hippocampal dendrites and occa-
tified several proteins in the postsynaptic density that sionally observed near synapses. Our data demonstrate
exhibit long-term activity-dependent changes in protein that blocking polyubiquitination or proteasome activity
levels and/or ubiquitination [5]. These proteins are po- prevents the agonist-induced internalization of GluRs,
tential candidates that may also exhibit acute regulation suggesting that the acute activation of GluRs leads to
by AMPA-stimulated proteasome activity. In addition, the regulation of ubiquitin conjugation system and the
proteins that are not contained in the postsynaptic den- degradation of a protein(s) required for the internaliza-
sity but can nevertheless regulate AMPA receptor endo- tion of the receptors. Synaptic activity might activate
cytosis are also potential targets. Finally, the observa- the ubiquitin conjugation system by working through a
tion that clusters of PSD proteins are coregulated by Ca2-sensitive [27] ubiquitin ligase [31, 32], or via Ca2-
global activity changes as well as the proteasome path- sensitive phosphorylation of the substrate, leading to
way [5] raises the possibility that AMPA receptor endo- its recognition by a ub-ligase (e.g., [33]). Alternatively,
cytosis may be controlled by the concerted regulation synaptic activity might inhibit deubiquitinating enzymes,
of several, rather than a single, synaptic proteasomal tilting the balance toward polyubiquitination and degra-
dation of substrates. In our experiments, pretreatmenttargets.
AMPA  ZL3VS, n  79, 64, 56, and 23, respectively. Scale bar, 10 m.
(E) Summary data for NMDA-induced internalization of GluR1. NMDA treatment resulted in an average 5.0-fold increase in fluorescence;
this increase was significantly inhibited by MG132. n for control, NMDA, and NMDA  MG132 are 47, 27, and 39, respectively.
(F) Shown are representative images of control, bicuculline- (BIC), or BIC  MG132-treated neurons in which internalization of GluR1 was
monitored in the dendrites of dissociated hippocampal neurons. BIC stimulation increased the pool of internalized GluR1; this internalization
was blocked by a 20 min pretreatment with MG132.
(G) Summary data for BIC-induced internalization of GluR1. Bicuculline treatment (40 min) resulted in an average 3.5-fold increase in
fluorescence; this increase was significantly inhibited by MG132. n for control, BIC, and BIC  MG132 are 40, 29, and 29, respectively.
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Figure 3. Proteasome Inhibitors Do Not Alter Surface GluRs or Block Transferrrin Endocytosis
(A) Representative images for either surface GluR1- or GluR2-labeled neurons treated with vehicle (control), MG132 for 10 min, or MG132 for
2 hr. Scale bar, 10 m.
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Figure 4. AMPA-Induced Internalization of GluR1 and GluR2 Requires Polyubiquitination; Brief  5 min MG132 Treatment Does Not Deplete
the Free Ubiquitin Pool
(A and B) Treatment of hippocampal neurons with MG132 for greater than 5 min results in decreased free ubiquitin as detected with Western
blot analysis. Data analyzed in (B) are normalized to actin, same lane, controls. (C and D) GluR1 or GluR2 internalization experiments were
performed on Sindbis GFP or Sindbis His6-myc-ubiquitin K48R-IRES-GFP-infected neurons. Shown is the GFP signal and the internalized
receptor signal for either GluR1 (C) or GluR2 (D). In GFP-expressing neurons, AMPA resulted in a robust internalization of either receptor. In
contrast, neurons expressing K48R-IRES-EGFP showed significantly reduced internalization following AMPA treatment. Scale bar, 10 m. (E)
Summary data for experiments in (C) and (D). n for GluR1: GFP, GFP  AMPA, Ub-K48R  AMPA, n  30, 64, and 67, respectively; GluR2:
GFP, GFP  AMPA, Ub-K48R  AMPA, n  36, 33, and 43, respectively.
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